Results 201 to 210 of about 1,454,174 (267)
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Strain diversity drives heterogeneous responses to tuberculosis combination therapy
Yoon MH +6 more
europepmc +1 more source
Intratumoral microbiota-derived S1P sensitizes the combination therapy of capecitabine and PD-1 inhibitors. [PDF]
Dai CS +7 more
europepmc +1 more source
Tumor mutational burden as a determinant of metastatic dissemination patterns
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal +4 more
wiley +1 more source
Safety and efficacy of relugolix combination therapy in symptomatic uterine fibroids. [PDF]
De Angelis MC +7 more
europepmc +1 more source
CASE STUDY THE EFFECT OF COMBINATION OF BABY MASSAGE AND LULLABY MUSIC THERAPY ON BABY SLEEP QUALITY
Muhammad Romadhon +2 more
openalex +2 more sources
The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli +7 more
wiley +1 more source
Azelastine-Fluticasone Combination Therapy in Allergic Rhinitis: Current Evidence and Clinical Implications in Children and Adults. [PDF]
Indolfi C +8 more
europepmc +1 more source

